Skip to content
Recall Observatory FDA recall evidence

Drug product

Lovastatin Tablets USP, 40 mg, packaged in a) 100-count bottles (NDC 68001-316-00) and b)1000-count bottles (NDC 68001-316-08), Rx Only, Manufactured by: Lupin Limited, Goa 403 722 INDIA For BluePoint Laboratories.

D-1584-2019

February 19, 2019

Class III

Product summary

Firm
American Health Packaging
Event
Event 83471
Status
Terminated
Classification
Class III
Quantity
14,360 bottles
Official record key
drug-enforcement:D-1584-2019

Official wording

Reason: CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results.

Code information: Lot #: a) G702705 and b) G702706, Exp. 3/31/2020

Distribution pattern: Nationwide within the USA and Puerto Rico

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations
  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification